Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MIT Holding Inc MITD

"MIT Holding Inc provides intravenous therapies to patients at their homes in the United States. Further through its affiliations and contractors, the company prepares intravenous medication for home infusion by the patient, administers intravenous infusions, provides medical management services, the ambulatory center where therapies are administered and sells and rents home medical equipment... see more

GREY:MITD - Post Discussion

MIT Holding Inc > MIT Holding, Inc. (MITD) Appoints Tommy J. Duncan to Preside
View:
Post by qualitystocks.net on Jan 20, 2015 6:38pm

MIT Holding, Inc. (MITD) Appoints Tommy J. Duncan to Preside

MIT Holding, Inc. (MITD) Appoints Tommy J. Duncan to President Role
 
Earlier today, MIT Holding announced that Tommy J. Duncan is now president of day-to-day operations at MIT Holding. This appointment corresponds with the company’s second phase of corporate re-organization.
 
“For the last 12 months, MIT Holding has focused on the assembly of a portfolio of licenses, contracts, agreements and working arrangements. Compilation of this portfolio has allowed the company to build, support and begin to offer a ‘one-stop-provider’ of services for patients in transition,” stated Duncan. “The health care system’s continual urging of quicker patient discharges creates an environment in which much of the recovery process and responsibility is forced upon the patient.
 
“Our goal is to ease this burden and create for patients a single source for all of their necessary medical products and services.”
 
The new company president will help expand MIT Holding’s offerings while also providing oversight and assistance in dealing with the insurance and government agencies involved in patient recovery costs.
 
“The expansion of these proven services will continue throughout Georgia as we aggressively begin looking at acquisitions and partnerships to start a nationwide roll-out of services,” commented Duncan.
 
In addition to his new position as president, Duncan is an independent director at MIT Holding. He previously served as president at Southeast Vending LLC and at Southeast Lumber & Construction, Inc. for which he successfully executed numerous mergers and acquisitions as well as identified and secured financing from multiple funding sources. During his tenures as secretary and treasurer at Auto Locators, Inc. and at Custom Locators USA, Inc., Duncan was recognized for his skills in identifying talented management and hiring them to key positions within each of those companies to accommodate corporate expansion in terms of size and revenues. His prior experience also includes serving on the board of directors at CNB Bancorp, Inc. (Windsor, Virginia).
 
For more information on MIT Holding, visit www.mitholdingsinc.com
 
Please see disclaimer on the QualityStocks website: https://Disclaimer.QualityStocks.com
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities